Table 2. Use of adjuvant systemic and/or intraperitoneal chemotherapy.
| Adenocarcinoma n (%) | Goblet cell carcinoid n (%) | |
|---|---|---|
| n (%) | 18/32 (56) | 17/38 (45) |
| Stage 1 | 0/3 (0) | 0/3 (0) |
| Stage 2 | 10/20 (50) | 13/30 (43) |
| Stage 3 | 8/9 (89) | 4/5 (80) |
| Adenocarcinoma n (%) | Goblet cell carcinoid n (%) | |
|---|---|---|
| n (%) | 18/32 (56) | 17/38 (45) |
| Stage 1 | 0/3 (0) | 0/3 (0) |
| Stage 2 | 10/20 (50) | 13/30 (43) |
| Stage 3 | 8/9 (89) | 4/5 (80) |